Cidofovir for cytomegalovirus (CMV) antigenemia after allogeneic stem cell transplantation.

被引：0
|
作者：
Soligo, D [1 ]
Tagliaferri, E [1 ]
Barraco, F [1 ]
Lambertenghi, D [1 ]
Della Volpe, A [1 ]
Deliliers, GL [1 ]
机构：
[1] Osped Maggiore, IRCCS, Ctr Trapianti Midollo, Milan, Italy
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4461
引用
收藏
页码：339B / 339B
页数：1
相关论文
共 50 条
  • [41] Frequent detection of rising cytomegalovirus antigenemia after allogeneic stem cell transplantation following a regimen containing antithymocyte globulin
    Kanda, Y
    Mineishi, S
    Nakai, K
    Saito, T
    Tanosaki, R
    Takaue, Y
    BLOOD, 2001, 97 (11) : 3676 - 3677
  • [42] Cidofovir for cytomegalovirus reactivation in pediatric patients after hematopoietic stem cell transplantation
    Cesaro, S
    Zhou, X
    Manzardo, C
    Buonfrate, D
    Cusinato, R
    Tridello, G
    Mengoli, C
    Palù, G
    Messina, C
    JOURNAL OF CLINICAL VIROLOGY, 2005, 34 (02) : 129 - 132
  • [43] Differences in Cytomegalovirus Replication Quantified Using Quantitative Polymerase Chain Reaction and Antigenemia After Allogeneic Stem Cell Transplantation
    de la Cruz-Vicente, F.
    Perez-Romero, P.
    Aguilar-Guisado, M.
    Cisneros-Herreros, J. M.
    Urbano-Ispizua, A.
    Espigado, I.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (08) : 3230 - 3231
  • [44] Cidofovir is effective and well tolerated in the treatment of patients with ganciclovir refractory cytomegalovirus infection after allogeneic stem cell transplantation
    Nagra, S.
    Duncan, N.
    Kishore, B.
    Osman, H.
    Mazumdar, S.
    Cook, M.
    Craddock, C.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S207 - S208
  • [45] Control of Cytomegalovirus Viremia after Allogeneic Stem Cell Transplantation: A Review on CMV-Specific T Cell Reconstitution
    van der Heiden, Pim
    Marijt, Erik
    Falkenburg, Fred
    Jedema, Inge
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (09) : 1776 - 1782
  • [46] Cytomegalovirus infections following reduced-intensity allogeneic stem cell transplantation.
    Nakamura, R
    Cohen, S
    Palmer, J
    Hawkins, G
    Tegtmeier, B
    Spielberger, R
    Smith, E
    Ito, J
    O'Donnell, MR
    Smith, D
    Zaia, JA
    Forman, SJ
    BLOOD, 2004, 104 (11) : 617A - 617A
  • [47] Extremely High Incidence of CMV-pp65 Antigenemia in ATLL Patients After Allogeneic Hematopoietic Stem Cell Transplantation
    Nakano, Nobuaki
    Kubota, Ayumu
    Tokunaga, Mashahito
    Takeuchi, Shogo
    Takatsuka, Yoshifusa
    Utsnomiya, Atae
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S237 - S237
  • [48] Identifying Cytomegalovirus Complications Using the Quantiferon-CMV Assay After Allogeneic Hematopoietic Stem Cell Transplantation
    Yong, Michelle K.
    Cameron, Paul U.
    Slavin, Monica
    Morrissey, C. Orla
    Bergin, Krystal
    Spencer, Andrew
    Ritchie, David
    Cheng, Allen C.
    Samri, Assia
    Carcelain, Guislaine
    Autran, Brigitte
    Lewin, Sharon R.
    JOURNAL OF INFECTIOUS DISEASES, 2017, 215 (11): : 1684 - 1694
  • [49] Cytomegalovirus infection after allogeneic haemopoetic stem cell transplantation
    Ovsjannikova, M
    Emeljanova, S
    Vinogradskaja, G
    Stancheva, N
    Semenova, E
    Zubarovskaya, L
    Afanasjev, B
    BONE MARROW TRANSPLANTATION, 2006, 37 : S177 - S177
  • [50] Cytomegalovirus (CMV) infection in allogeneic non-myeloablative stem cell transplantation recipients
    Chandrasekar, P
    King, R
    Dansey, R
    Akhtar, A
    Mellon-Reppen, S
    Alangaden, G
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 43 - 43
12345